Abstract
Background The neurodevelopmental progress of infants (age below 3 months) is globally not well described, and a lack of published data on normative values of child development in this age group has been identified. In South Africa, the description of neurodevelopmental characteristics of infants at well-baby 6- and 10-week visits are omitted from the ‘Road to Health Booklet’, a nationally used patient-held clinical record. The neurodevelopmental status of infants in these age groups is thus not routinely monitored and the data is not documented. Important changes occur in the maturation of the central nervous system of infants at 6 weeks that signify this age as an important milestone for monitoring neurodevelopmental progress.
Methodology and findings A prospective longitudinal study was performed on a sample of 35 term-born healthy, infants from low-risk pregnancies at 6- and 10-weeks postnatal age in the Tshwane District, South Africa. The Hammersmith Neonatal Neurological Examination systematically recorded the status of posture, tone, reflexes, movements, orientation and behaviour in these age groups. Compound and total examination optimal scores were derived from raw scores of 34 neurological items in the proforma evaluation form by using cut-off points on the 5th, 10th, and 90th percentiles. Infants who attended both the 6- and 10-week clinic visits were included. This study quantitatively confirmed consistent patterns of characteristic change occurring in muscle tone, posture, and visual behaviour of infants between 6 and 10 weeks.
Conclusion and significance This study successfully recorded data on the neurodevelopmental assessment of infants from low-risk pregnancies at 6- and 10-weeks post-term age in Tshwane District, South Africa. The compound and total examination optimality scores obtained in this study can presently guide health care professionals using this method of examination in the early identification of adverse neurological signs in such young infants.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research Ethics Committee of the University of Pretoria, South Africa, gave ethical approval for this work. Reference number 283/2019
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.